Logo do repositório
 
Publicação

Point-of-care HIV and hepatitis screening in community pharmacies

2022-10Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorFigueira, Inês
dc.contributor.authorTeixeira, Inês
dc.contributor.authorRodrigues, António Teixeira
dc.contributor.authorGama, Ana
dc.contributor.authorDias, Sónia
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.institutionComprehensive Health Research Centre (CHRC) - Pólo ENSP
dc.contributor.institutionCentro de Investigação em Saúde Pública (CISP/PHRC)
dc.contributor.pblSpringer Science and Business Media Deutschland GmbH
dc.date.accessioned2023-01-23T22:16:26Z
dc.date.available2023-01-23T22:16:26Z
dc.date.issued2022-10
dc.descriptionFunding Information: The study was funded by the National Association of Pharmacies. The sponsor had no role in the study design; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
dc.description.abstractBackground: Point-of-care tests can contribute to earlier diagnosis and treatment of infectious diseases, thereby affording the opportunity to prevent chronic stages and the spread to others. As part of the Fast-Track Cities initiative, a pilot study was initiated in community pharmacies in Portugal. Aim: To characterize the individuals choosing to have point-of-care testing or screening for human immunodeficiency virus, hepatitis C, and hepatitis B virus infections in community pharmacies, their risk behaviours and motivations to perform the tests, as well as to understand the facilitators and barriers from the perspective of pharmacists. Method: A quantitative and qualitative study was conducted. A survey was applied to test users in pharmacies between May and December 2019, and three focus groups were conducted with six, four, and five pharmacists involved in the initiative. Qualitative data were analysed according to thematic content analysis. Results: A total of 210 questionnaires were collected (57.9% response rate). Point-of-care test users were predominantly male, mean age of 35 (± 13.0) years, the majority had higher education level, and 22.8% were born outside of Portugal. Almost half of the users were first time tested and the main reason for screening was unprotected sexual intercourse. Pharmacists identified speed, confidentiality, counselling provided to users, pharmacists’ initial training to perform the tests, and trust in the pharmacist as facilitators of these tests. Stigma associated with infections, the procedure, logistical conditions, and the referral process were considered as barriers. Conclusion: Pharmacies are a screening site with special importance for individuals who are first tested, heterosexuals, and some migrants. Nevertheless, it is necessary to understand and reduce barriers and increase the support to specific groups.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent11
dc.format.extent904814
dc.identifier.doi10.1007/s11096-022-01444-1
dc.identifier.issn2210-7703
dc.identifier.otherPURE: 51404358
dc.identifier.otherPURE UUID: 26e28202-38dd-47a0-a4e2-b9c1cd29045c
dc.identifier.otherScopus: 85138155052
dc.identifier.otherPubMed: 36098836
dc.identifier.otherWOS: 000853977400002
dc.identifier.otherPubMedCentral: PMC9469055
dc.identifier.otherORCID: /0000-0001-5085-0685/work/131110365
dc.identifier.urihttp://hdl.handle.net/10362/148031
dc.identifier.urlhttps://www.scopus.com/pages/publications/85138155052
dc.language.isoeng
dc.peerreviewedyes
dc.subjectBarriers
dc.subjectCommunity pharmacy
dc.subjectFacilitators
dc.subjectPoint-of-care tests
dc.subjectPharmacy
dc.subjectToxicology
dc.subjectPharmacology
dc.subjectPharmaceutical Science
dc.subjectPharmacology (medical)
dc.subjectSDG 3 - Good Health and Well-being
dc.titlePoint-of-care HIV and hepatitis screening in community pharmaciesen
dc.title.subtitlea quantitative and qualitative studyen
dc.typejournal article
degois.publication.firstPage1158
degois.publication.issue5
degois.publication.lastPage1168
degois.publication.titleINTERNATIONAL JOURNAL OF CLINICAL PHARMACY
degois.publication.volume44
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
Figueira_Int_J_Clin_Pharm_2022_44_5_1158.pdf
Tamanho:
883.61 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

Home collection (ENSP)